Cholestatic syndromes

Area of Science:

• Hepatology
• Molecular Pathogenesis
• Clinical Gastroenterology

Background:

• Cholestasis encompasses a range of clinical disorders characterized by impaired bile flow.
• Understanding the molecular mechanisms underlying cholestasis is crucial for effective treatment.

Purpose of the Study:

• To review recent developments in the molecular pathogenesis of cholestasis.
• To highlight new aspects of pathogenesis and management for clinical cholestatic disorders.

Main Methods:

• Literature review of recent scientific publications.
• Synthesis of findings on molecular mechanisms, genetic factors, and therapeutic targets.
• Analysis of clinical studies across various cholestatic syndromes.

Main Results:

• Identification of nuclear receptors, such as FXR ligands, as potential therapeutic agents.
• Discovery of new genetic defects contributing to pediatric cholestasis and sclerosing cholangitis.
• Emergence of novel infections and environmental agents as etiologies for primary biliary cirrhosis.
• Review of significant clinical studies on pediatric cholestatic syndromes, intrahepatic cholestasis of pregnancy, primary biliary cirrhosis, sclerosing cholangitis, cholestasis of sepsis, viral cholestatic syndromes, and drug-induced cholestasis.

Conclusions:

• Recent advances enhance the understanding of cholestatic liver disease pathophysiology.
• Improved diagnostic approaches and management strategies are emerging.
• Targeted therapies, informed by molecular insights, show promise for treating cholestatic disorders.